The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Salvia miltiorrhiza in Treating Cardiovascular Diseases: A Review on Its Pharmacological and Clinical Applications
Open accessAbstract
Bioactive chemical constitutes from the root of Salvia miltiorrhiza classified in two major groups, viz; liposoluble tanshinones and water-soluble phenolics. Tanshinone IIA is a major lipid soluble compound having promising health benefits. The in vivo and in vitro studies showed that the tanshinone IIA and salvianolate have a wide range of cardiovascular and other pharmacological effects, including antioxidative, anti-inflammatory, endothelial protective, myocardial protective, anticoagulation, vasodilation, and anti-atherosclerosis, as well as significantly help to reduce proliferation and migration of vascular smooth muscle cells. In addition, some of the clinical studies reported that the S. miltiorrhiza preparations in combination with Western medicine were more effective for treatment of various cardiovascular diseases including angina pectoris, myocardial infarction, hypertension, hyperlipidemia, and pulmonary heart diseases. In this review we demonstrated the potential applications of S. miltiorrhiza, including pharmacological effects of salvianolate, tanshinone IIA and its water-soluble derivative like sodium tanshinone IIA sulfonate, moreover we also provided details about the clinical applications of S. miltiorrhiza preparations in controlling the cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wu, D., Wang, Y., Han, X., Wen, X., Li, L., Xu, L., Lu, J., & Zheng, Y. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13557 · Cited by 55
RetractedZhao, D., Tong, L., Zhang, L., Li, H., Wan, Y., & Zhang, T. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5916 · Cited by 38
RetractedHeart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Cardiovascular disease in Europe: epidemiological update
Nichols, M., Townsend, N., Scarborough, P., & Rayner, M. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht356 · Cited by 1,343
Cardiovascular disease in Europe 2014: epidemiological update
Nichols, M., Townsend, N., Scarborough, P., & Rayner, M. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu299 · Cited by 1,294
Recent insights into the cellular biology of atherosclerosis
Tabas, I., García-Cardeña, G., & Owens, G. K. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201412052 · Cited by 1,016
Controversies in ventricular remodelling
Opie, L. H., Commerford, P. J., Gersh, B. J., & Pfeffer, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68074-4 · Cited by 861
Tsang, A., Hausenloy, D. J., Mocanu, M. M., & Yellon, D. M. (2004) · Circulation Research · doi:10.1161/01.res.0000138303.76488.fe · Cited by 661
Epidemiological studies of CHD and the evolution of preventive cardiology
Wong, N. D. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.26 · Cited by 658
Traditional Chinese Medicine for Cardiovascular Disease
Hao, P., Jiang, F., Cheng, J., Ma, L., Zhang, Y., & Zhao, Y. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.041 · Cited by 580
Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics
Li, Z.-M., Xu, S.-W., & Liu, P.-Q. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.193 · Cited by 564
Imaging of atherosclerotic cardiovascular disease
Sanz, J., & Fayad, Z. A. (2008) · Nature · doi:10.1038/nature06803 · Cited by 558
Endothelial–mesenchymal transition in atherosclerosis
Souilhol, C., Harmsen, M. C., Evans, P. C., & Krenning, G. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvx253 · Cited by 401
Cardiovascular actions and therapeutic potential of tanshinone IIA
Gao, S., Liu, Z., Li, H., Little, P. J., Liu, P., & Xu, S. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.041 · Cited by 359
Li, X., Zhang, J., Huang, J., Ma, A., Yang, J., Li, W., Wu, Z., Yao, C., Zhang, Y., Yao, W., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.035 · Cited by 336
Self-citationTrends in Coronary Heart Disease Epidemiology in India
Gupta, R., Mohan, I., & Narula, J. (2016) · Annals of Global Health · doi:10.1016/j.aogh.2016.04.002 · Cited by 320
Lu, Z., Kou, W., Du, B., Wu, Y., Zhao, S., Brusco, O. A., Morgan, J. M., & Capuzzi, D. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.056 · Cited by 315
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
Xu, S., Ogura, S., Chen, J., Little, P. J., Moss, J., & Liu, P. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1194-z · Cited by 293
Hyperuricemia and Incidence of Hypertension Among Men Without Metabolic Syndrome
Krishnan, E., Kwoh, C. K., Schumacher, H. R., & Kuller, L. (2007) · Hypertension · doi:10.1161/01.hyp.0000254480.64564.b6 · Cited by 293
Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection
Ho, J., & Hong, C.-Y. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-30 · Cited by 292
Shihab, H. M., Meoni, L. A., Chu, A. Y., Wang, N.-Y., Ford, D. E., Liang, K.-Y., Gallo, J. J., & Klag, M. J. (2012) · Circulation · doi:10.1161/circulationaha.112.117333 · Cited by 274
Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
Zhang, Y., Jiang, P., Ye, M., Kim, S.-H., Jiang, C., & Lü, J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131013621 · Cited by 257
Sex Differences in Hypertension: Where We Have Been and Where We Are Going
Ramirez, L. A., & Sullivan, J. C. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy148 · Cited by 216
Pulmonary Diseases and the Heart
Han, M. K., McLaughlin, V. V., Criner, G. J., & Martinez, F. J. (2007) · Circulation · doi:10.1161/circulationaha.106.685206 · Cited by 215
BOPASSA, J., FERRERA, R., GATEAUROESCH, O., COUTURELEPETIT, E., & OVIZE, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.07.014 · Cited by 205
Antioxidant Therapeutic Strategies for Cardiovascular Conditions Associated with Oxidative Stress
Farías, J., Molina, V., Carrasco, R., Zepeda, A., Figueroa, E., Letelier, P., & Castillo, R. (2017) · Nutrients · doi:10.3390/nu9090966 · Cited by 194
Lu, T. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.08.013 · Cited by 192
Sun, M., Shi, M., Wang, Y., Huang, Q., Yuan, T., Wang, Q., Wang, C., Zhou, W., & Kai, G. (2018) · Journal of Experimental Botany · doi:10.1093/jxb/ery349 · Cited by 154
Self-citationThe involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis
Fenyo, I. M., & Gafencu, A. V. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.06.005 · Cited by 149
Dyslipidaemia as a predictor of hypertension in middle-aged men
Laaksonen, D. E., NISKANEN, L. K., Nyyssönen, K., Lakka, T. A., Laukkanen, J. A., & SALONEN, J. T. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn061 · Cited by 149
Feng, X., Li, Y., Wang, Y., Li, L., Little, P. J., Xu, S., & Liu, S. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.006 · Cited by 142
Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia
Xie, W., Zhao, Y., & Du, L. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.01.027 · Cited by 130
Atheroprotective Effects and Molecular Targets of Tanshinones Derived From Herbal Medicine Danshen
Fang, J., Little, P. J., & Xu, S. (2017) · Medicinal Research Reviews · doi:10.1002/med.21438 · Cited by 129
Μaione, F., Feo, V. D., Caiazzo, E., Martino, L. D., Cicala, C., & Mascolo, N. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.07.010 · Cited by 124
Recent Advances in Managing Atherosclerosis via Nanomedicine
Chan, C. K. W., Zhang, L., Cheng, C. K., Yang, H., Huang, Y., Tian, X. Y., & Choi, C. H. J. (2017) · Small · doi:10.1002/smll.201702793 · Cited by 122
Zhou, W., Huang, Q., Wu, X. B., Zhou, Z., Ding, M., Shi, M., Huang, F., Shen, L., Wang, Y., & Kai, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-10215-2 · Cited by 121
Self-citationTherapeutic Effects of Breviscapine in Cardiovascular Diseases: A Review
Gao, J., Chen, G., He, H., Liu, C., Xiong, X., Li, J., & Wang, J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00289 · Cited by 120
Oxygen Radical-mediated Reduction in Basal and Agonist-evoked NO Release in Isolated Rat Heart
Paolocci, N., Biondi, R., Bettini, M., Lee, C.-I., Berlowitz, C. O., Rossi, R., Xia, Y., Ambrosio, G., Abbate, A. L., Kass, D. A., et al. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1334 · Cited by 113
Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer
Chen, W., Lu, Y., Chen, G., & Huang, S. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113139990115 · Cited by 104
Xu, S., Bai, P., Little, P. J., & Liu, P. (2013) · Medicinal Research Reviews · doi:10.1002/med.21300 · Cited by 99
IRAK1/4-Targeted Anti-Inflammatory Action of Caffeic Acid
Yang, W. S., Jeong, D., Yi, Y., Park, J. G., Seo, H., Moh, S. H., Hong, S., & Cho, J. Y. (2013) · Mediators of Inflammation · doi:10.1155/2013/518183 · Cited by 96
Chow, C., Cardona, M., Raju, P. K., Iyengar, S., Sukumar, A., Raju, R., Colman, S., Madhav, P., Raju, R., Srinath Reddy, K., et al. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.03.043 · Cited by 95
Tanshinone IIA suppresses cholesterol accumulation in human macrophages: role of heme oxygenase-1
Liu, Z., Wang, J., Huang, E., Gao, S., Li, H., Lü, J., Tian, K., Little, P. J., Shen, X., Xu, S., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m040394 · Cited by 94
Li, Q., Shen, L., Wang, Z., Jiang, H., & Liu, L. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.09.014 · Cited by 93
Qiu, H., Liu, W., Lan, T., Pan, W., Chen, X., Wu, H., & Xu, D. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.238 · Cited by 90
Regulation of Water-Soluble Phenolic Acid Biosynthesis in Salvia miltiorrhiza Bunge
Ma, P., Liu, J., Zhang, C., & Liang, Z. (2013) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-013-0265-4 · Cited by 88
Thawornchaisit, P., de Looze, F. J., Reid, C. M., Seubsman, S., & Sleigh, A. C. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002826 · Cited by 83
Chang, C., Chu, C.-F., Wang, C., Wu, H., Bi, K.-W., Pang, J. S., & Huang, S. (2013) · Phytomedicine · doi:10.1016/j.phymed.2013.09.012 · Cited by 83
Qiang, G., Yang, X., Shi, L., Zhang, H., Chen, B., Zhao, Y., Zu, M., Zhou, D., Guo, J., Yang, H., et al. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430258 · Cited by 80
Hu, H., Zhai, C., Qian, G., Gu, A., Liu, J., Fang, Y., Xu, W., Jin, D., Wang, H., Hu, H., et al. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1005753 · Cited by 80
Guo, Z., Yan, M., Chen, L., Fang, P., Li, Z., Wan, Z., Cao, S., Hou, Z., Wei, S., Li, W., et al. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6614 · Cited by 77
Tian, G., Sun, Y., Liu, S., Li, C., Chen, S., Qiu, R., Zhang, X., Li, Y., Li, M., & Shang, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01005 · Cited by 70
Wang, J., Jiang, Q., Wan, L., Yang, K., Zhang, Y., Chen, Y., Wang, E. Y., Lai, N., Zhao, L., Jiang, H., et al. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0071oc · Cited by 67
Incident hypertension and its predictors
Talaei, M., Sadeghi, M., Mohammadifard, N., Shokouh, P., Oveisgharan, S., & Sarrafzadegan, N. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32836591d4 · Cited by 59
Yang, J., Pan, Y., Ge, J., Chen, B., Mao, W., Qiu, Y., & Wang, X. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452537 · Cited by 59
Chu, S.-M., Shih, W., Yang, Y., Chen, P., & Chu, Y.-H. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.03.047 · Cited by 56
Wang, B., Ge, Z., Cheng, Z., & Zhao, Z. (2017) · Biology Open · doi:10.1242/bio.024133 · Cited by 56
Kong, Q., Dai, L., Wang, Y., Zhang, X., Li, C., Jiang, S., Li, Y., Ding, Z., & Liu, L. (2016) · Scientific Reports · doi:10.1038/srep33636 · Cited by 54
Different network pharmacology mechanisms of Danshen-based Fangjis in the treatment of stable angina
Zhang, G., Zhang, Y., Zhang, X., Wang, P., Liu, J., Liu, Q., & Wang, Z. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.191 · Cited by 53
Wang, X., Wáng, Y., Jiang, M., Zhu, Y., Hu, L., Fan, G., Wang, Y., Li, X., & Gao, X. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.03.070 · Cited by 52
Yan, X., Gao, Y., Huang, H., Wang, X., Cai, Y., & Luan, Q. X. (2017) · Inflammation · doi:10.1007/s10753-017-0603-8 · Cited by 52
Shi, L., Xie, Y., Liao, X., Chai, Y., & Luo, Y. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0939-2 · Cited by 50
Aladin, A. I., Rifai, M. A., Rasool, S. H., Keteyian, S. J., Brawner, C. A., Michos, E. D., Blaha, M. J., Al-Mallah, M. H., & McEvoy, J. W. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpv095 · Cited by 48
Yuan, X., Jing, S., Wu, L., Chen, L., & Fang, J. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1820 · Cited by 47
Yang, L.-L., Li, D., Zhang, Y.-B., Zhu, M., Chen, D., & Xu, T. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.133 · Cited by 46
Feng, J., Li, S., & Chen, H. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.09.041 · Cited by 46
Omega‐3 fatty acids in coronary heart disease: Recent updates and future perspectives
Ajith, T. A., & Jayakumar, T. G. (2018) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13034 · Cited by 45
Danshen (Chinese medicinal herb) preparations for acute myocardial infarction
Wu, T., Ni, J., & Wei, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004465.pub2 · Cited by 44
Luo, J., Xu, H. P., & Chen, K. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/808076 · Cited by 41
Huang, D., Wei, X., Mu, H., Pan, C., Li, Q., Hu, B., Chang, X., Yan, L., Fan, J., Liu, Y., et al. (2018) · Shock · doi:10.1097/shk.0000000000001185 · Cited by 39
Wang, C., Luo, H., Xu, Y., Tao, L., Chang, C., & Shen, X. (2018) · Medical Science Monitor · doi:10.12659/msm.908936 · Cited by 38
Jia, L., Zhang, N., Xu, Y., Chen, W., Zhu, M.-L., Song, N., Ren, L., Cao, H., Wang, J., & Yang, G. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.01.001 · Cited by 37
Lǐ, Y., Xu, Q., Xu, W., Guo, X., Zhang, S., & Chen, Y. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.01.007 · Cited by 36
Wang, J., Lu, W., Wang, W., Zhang, N., Wu, H., Liu, C., Chen, X., Chen, Y., Chen, Y., Jiang, Q., et al. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2013.02.04 · Cited by 34
Tanshinone IIA protects rabbits against LPS-induced disseminated intravascular coagulation (DIC)
Wu, L., Lin, X., & Sun, H. X. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.84 · Cited by 34
Tsujimoto, T., Sairenchi, T., Iso, H., Irie, F., Yamagishi, K., Tanaka, K., Muto, T., & Ota, H. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328352b879 · Cited by 34
Compound Danshen Dripping Pill Inhibits Retina Cell Apoptosis in Diabetic Rats
Zhang, Q., Xiao, X., Zheng, J., Li, M., Yu, M., Ping, F., Wang, T., & Wang, X. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01501 · Cited by 32
Shou, Q., Pan, Y., Xu, X., Xu, J., Wang, D., Ling, Y., & Chen, M. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.044 · Cited by 31
The Endothelium in Diabetic Nephropathy
Gilbert, R. E. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0410-8 · Cited by 31
Yang, M.-C., You, F.-L., Wang, Z., Liu, X.-N., & Wang, Y. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.08.005 · Cited by 31
Li, Y., Guo, Y., Chen, Y., Wang, Y., You, Y., Yang, Q., Weng, X., Li, Q., Zhu, X., Zhou, B., et al. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3668 · Cited by 30
Zou, J., Zhang, X., Wang, J., Wang, F., Cheng, J., Yang, F.-Y., Song, X., Wang, Y., Liang, Y., & Shi, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00550 · Cited by 29
Fei, A., Cao, Q., Chen, S., Wang, H., Wang, F., Pan, S., & Lin, Z. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.209 · Cited by 28
Pan, C., Chen, C.-W., Sheu, M., & Wu, C. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.11.008 · Cited by 28
Salvianolate injection in the treatment of unstable angina pectoris
Zhang, D., Wu, J., Liu, S., Zhang, X., & Zhang, B. (2016) · Medicine · doi:10.1097/md.0000000000005692 · Cited by 28
Pan, Y., Qian, J.-X., Lu, S., Chen, J.-W., Zhao, X.-D., Jiang, Y., Wang, L., & Zhang, G. (2017) · PubMed Central · doi:10.22038/ijbms.2017.8361 · Cited by 28
Tanshinone IIA ameliorated endothelial dysfunction in rats with chronic intermittent hypoxia
Chen, L., Guo, Q., Chang, Y., Zhao, Y., Li, A., & Ji, E. (2017) · Cardiovascular Pathology · doi:10.1016/j.carpath.2017.06.008 · Cited by 27
Chen, T., Li, M., Fan, X., Cheng, J., & Wang, L. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6712585 · Cited by 27
Yu, M., Li, S., Gao, X., Li, J., Xu, H., & Chen, K. (2018) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-018-2556-7 · Cited by 23
Li, L., Sha, Z., Wang, Y., Yang, D., Li, J., Duan, Z., Wang, H., & Li, Y. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7462 · Cited by 23
Combined impact of risk factors on the subsequent development of hypertension
Huang, Y., Deng, Z., Se, Z., Bai, Y., Yan, C., Zhan, Q., Zeng, Q., Ouyang, P., Dai, M., & Xu, D. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001956 · Cited by 22
Makino, H., Miyamoto, Y., Kikuchi‐Taura, A., Soma, T., Taguchi, A., & Kishimoto, I. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12310 · Cited by 21
Lu, M., Luo, Y., Hu, P., Dou, L., & Huang, S. (2018) · PubMed Central · doi:10.22038/ijbms.2017.20100.5276 · Cited by 21
Mao, S., Li, W., Qa’aty, N., Vincent, M. L., Zhang, M., & Hinek, A. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.191 · Cited by 20
Mao, S., Li, X., Wang, L., Yang, P. C.-M., & Zhang, M. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6625-2 · Cited by 20
Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure
He, Z., Sun, C., Xu, Y., & Cheng, D. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.110 · Cited by 20
Anupama, Y. J., Hegde, S. N., Uma, G., & Patil, M. (2016) · Journal of Human Hypertension · doi:10.1038/jhh.2016.81 · Cited by 20
Morio, M., Inoue, M., Inoue, K., & Akimoto, K. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-81 · Cited by 16
Sodium Tanshinone IIA Sulfonate Prevents Radiation‐Induced Toxicity in H9c2 Cardiomyocytes
Zhang, W., Li, Y., Li, R., Wang, Y., Zhu, M., Wang, B., Li, Y., Li, D., Xie, P., & Liu, B. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/4537974 · Cited by 16
Cheng, Q., Zhao, Y., & Li, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6760 · Cited by 16
Plasma asymmetric dimethylarginine predicts restenosis after coronary angioplasty
Derkacz, A., Protasiewicz, M., Poręba, R., Doroszko, A., Poręba, M., Antonowicz−Juchniewicz, J., Andrzejak, R., & Szuba, A. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.23410 · Cited by 15
Tanshinone-induced ERs suppresses IGFII activation to alleviate Ang II-mediated cardiac hypertrophy
Chen, Y., Lee, N., Pai, P., Chung, L.-C., Shen, C.-Y., Rajendran, P., Chen, Y.-F., Chen, R., Viswanadha, V. P., Kuo, W., et al. (2017) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2017.1360349 · Cited by 15
Pang, J., Hu, P.-Y., Wang, J., Jiang, J., & Lai, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10211 · Cited by 13
Qian, C., Ren, Y., & Xia, Y. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.10.008 · Cited by 12
Comparison of coronary artery disease guidelines with extracted knowledge from data mining
Rezaei‐Hachesu, P., Oliyaee, A., Safaie, N., & Ferdousi, R. (2017) · Journal of Cardiovascular and Thoracic Research · doi:10.15171/jcvtr.2017.16 · Cited by 12
Zhang, Q., Jiao, F., & Chongjun, H. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4114 · Cited by 9
DOLPHIN investigator group, Chen, A.-D., Wang, C., Qin, Y., Tian, L., Chen, L., Yuan, X.-M., Ma, L.-X., Wang, Y., Sun, J.-R., et al. (2017) · Trials · doi:10.1186/s13063-017-2336-2 · Cited by 9
Zhu, Z., Wang, Y., Liao, W., Li, H., & Wang, D. (2018) · Medicine · doi:10.1097/md.0000000000011062 · Cited by 8
Liu, D., Yang, G., Zhao, X., & Yang, H. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6264 · Cited by 5
Cited by
Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety
Shaito, A., Thuan, D. T. B., Phu, H. T., Nguyen, T. H. D., Hasan, H., Halabi, S., Abdelhady, S., Nasrallah, G. K., Eid, A. H., & Pintus, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00422 · Cited by 437
Ashraf, M. V., Khan, S., Misri, S., Gaira, K. S., Rawat, S., Rawat, B., Khan, M. A. H., Shah, A. A., Asgher, M., & Ahmad, S. (2024) · Pharmaceuticals · doi:10.3390/ph17080975 · Cited by 102
Recent advances of tanshinone in regulating autophagy for medicinal research
Wu, S., Zhao, K., Wang, J., Liu, N., Nie, K., Qi, L., & Xia, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1059360 · Cited by 32
Spirulina and Herbal Combination on Metabolic Alterations of Cardiovascular Diseases (CVDs)
Pandey, R., & Singh, S. (2022) · International Journal of Research and Review · doi:10.52403/ijrr.20220334 · Cited by 6
Metadata
- Authors
- Ren, J., Fu, L., Nile, S. H., Zhang, J., & Kai, G.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2019-07-05
- Volume
- 10
- Pages
- 753-753
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2954366821
- Cited by
- 305
- References
- 109
- FWCI
- 38.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.